Showing results (241-250 of 454) with videos related to

Sort By:
Pageof 46
Transplantation|December 2, 2016
Successful Continuation of HCV Treatment After Liver TransplantationCarlos Fernández Carrillo, Gonzalo Crespo, Juan de la Revilla, et al.
JHEP Reports : Innovation in Hepatology|February 15, 2024
Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failureChristiana Graf, Roberta D'Ambrosio, Elisabetta Degasperi, et al.
BMC Medicine|May 4, 2017
Late presentation of chronic viral hepatitis for medical care: a consensus definitionStefan Mauss, Stanislas Pol, Maria Buti, et al.
Digestive Diseases and Sciences|September 3, 2014
Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis BNaoky C Tsai, Patrick Marcellin, Maria Buti, et al.
The American Journal of Gastroenterology|February 18, 2011
Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized studyIñigo Les, Eduardo Doval, Rita García-Martínez, et al.
Annals of the New York Academy of Sciences|August 4, 2015
Development of sofosbuvir for the treatment of hepatitis C virus infectionEric Lawitz, Ira M Jacobson, David R Nelson, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2020
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort studyPietro Lampertico, Thomas Berg, Maria Buti, et al.
Hepatology Communications|January 8, 2020
Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis BAnna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
Gastroenterology|September 27, 2013
Telbivudine improves renal function in patients with chronic hepatitis BEdward J Gane, Gilbert Deray, Yun-Fan Liaw, et al.
European Journal of Gastroenterology & Hepatology|May 4, 2016
Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b studyStefan Zeuzem, Parvez Mantry, Vicente Soriano, et al.
Pageof 46